Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? Doshi P. BMJ 2026;393:s666.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Doshi P. Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? BMJ 2026;393:s666.
PMID: 41985930